Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis
Clinical trial NCT03355365 · COMPLETED
Trial details
- NCT number
- NCT03355365
- Sponsor
- Tisch Multiple Sclerosis Research Center of New York
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-21
- Primary completion
- 2023-02-09
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.